Your browser doesn't support javascript.
loading
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features.
Magaret, Craig A; Benkeser, David C; Williamson, Brian D; Borate, Bhavesh R; Carpp, Lindsay N; Georgiev, Ivelin S; Setliff, Ian; Dingens, Adam S; Simon, Noah; Carone, Marco; Simpkins, Christopher; Montefiori, David; Alter, Galit; Yu, Wen-Han; Juraska, Michal; Edlefsen, Paul T; Karuna, Shelly; Mgodi, Nyaradzo M; Edugupanti, Srilatha; Gilbert, Peter B.
Afiliação
  • Magaret CA; Vaccine and Infectious Disease Division and Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Benkeser DC; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
  • Williamson BD; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
  • Borate BR; Vaccine and Infectious Disease Division and Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Carpp LN; Vaccine and Infectious Disease Division and Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Georgiev IS; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • Setliff I; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • Dingens AS; Department of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, Tennessee, United States of America.
  • Simon N; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • Carone M; Program in Chemical & Physical Biology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • Simpkins C; Division of Basic Sciences and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Montefiori D; Division of Human Biology and Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Alter G; Molecular and Cellular Biology PhD Program, University of Washington, Seattle, Washington, United States of America.
  • Yu WH; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
  • Juraska M; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
  • Edlefsen PT; Vaccine and Infectious Disease Division and Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Karuna S; Duke University School of Medicine, Duke University, Durham, North Carolina, United States of America.
  • Mgodi NM; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
  • Edugupanti S; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
  • Gilbert PB; Vaccine and Infectious Disease Division and Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
PLoS Comput Biol ; 15(4): e1006952, 2019 04.
Article em En | MEDLINE | ID: mdl-30933973

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína gp160 do Envelope de HIV / Anticorpos Monoclonais Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS Comput Biol Assunto da revista: BIOLOGIA / INFORMATICA MEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína gp160 do Envelope de HIV / Anticorpos Monoclonais Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS Comput Biol Assunto da revista: BIOLOGIA / INFORMATICA MEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos